Key result
Female sex shows no association with higher operative mortality after mitral valve surgery.
Why the study?
It remained unclear whether sex is an independent risk factor associated with perioperative mortality after mitral valve surgery despite differences in operative characteristics.
Does female sex increase operative mortality in adult patients undergoing mitral valve surgery?
Does female sex increase operative mortality in adult patients undergoing mitral valve surgery?
Despite presenting with worse baseline heart failure symptoms and being less likely to undergo valve repair, women do not have a significantly higher risk of operative mortality following mitral valve surgery compared to men.
Reassures clinicians referring women for mitral valve surgery; challenges prior evidence of excess female operative mortality risk.
Background Despite differences in operative characteristics in patients with mitral valve disease, it remains unclear if sex is an independent risk factor associated with perioperative mortality after mitral valve surgery. Methods We performed a retrospective cohort study of 3313 adult patients who underwent mitral valve surgery between 2011 and 2024 at 2 academic institutions. Patients were stratified by sex, and the primary outcome was operative mortality. Multivariable logistic regression was used to identify independent predictors of operative mortality. Results In our cohort, 44.5% were women. Women were older (63.9 versus 62.2 years, P <0.0001), more likely to have New York Heart Association class III (15.9% versus 7.6%) and IV (1.4 versus 1.1%) heart failure ( P <0.05 for both), and less likely to undergo mitral valve repair (63.5% versus 80.0%, P <0.0001). Women had shorter cross‐clamp times (101.1 versus 105.0 min, P <0.01). Although postoperative intensive care unit stay was longer for women (3.0 versus 2.3 days, P <0.0001), operative mortality did not differ significantly by sex (1.42% versus 0.92%, P =0.32). In multivariable regression, female sex was not significantly associated with mortality after adjusting for covariates (odds ratio [OR], 1.03 [95% CI, 0.39–2.77], P =0.66). Prolonged cardiopulmonary bypass time was significantly associated with an increased odds of postoperative mortality (OR, 1.01 per 10 minutes [95% CI, 1.01–1.02], P =0.002). Conclusions Despite differences in baseline characteristics and surgical approach, operative mortality did not differ significantly by sex. Female sex was not significantly associated with operative mortality after adjustment for clinical and operative factors in patients undergoing elective mitral valve surgery.
No takes yet. Share an insight, caveat, or question.
Kubi et al. (2026) studied this question. Female sex was not significantly associated with operative mortality after mitral valve surgery (OR 1.03, 95% CI 0.39-2.77), with unadjusted mortality at 1.42% for women and 0.92% for men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: